EDX Medical Group Plc has joined forces with leading NHS and government health bodies to deliver a rapid hospital-acquired pneumonia test. Sir Chris Evans explains why this partnership could change patient outcomes, cut costs, and accelerate the UK’s precision medicine agenda...
EDX Medical will partner with the Intensive Care Unit at Cambridge University Hospitals NHS Foundation Trust to support the further advancement of a highly precise test that identifies the DNA or RNA of the microbes that cause lung infection in critically ill patients...
CEO Andrew Hume walks us through a significant new agreement with Metals One, a deal that brings in capital and specialist partners while allowing Thor to retain upside exposure..
Stephane Foucaud of Auctus Advisors reveals how robust execution and a cash-rich balance sheet are fuelling both growth and shareholder value. Investors should keep Valeura firmly on their radar...
The trust delivered an exceptional share price performance of +9.9%. This significantly outperformed both the NAV growth (+3.8%) and the FTSE All-World Index (+4.8%)...
New Frontier Minerals has released an expanded suite of preliminary metallurgical results at its Big One Deposit, validating its fast-track production strategy..
Hercules Plc CEO Brusk Korkmaz and CFO Paul Wheatcroft break down their acquisition of Advantage NRG Ltd., explaining why this move anchors the company firmly in the UK’s infrastructure surge..
Leveraging the Prime Oil & Gas amalgamation, the company has doubled its reserves and production base, enabling it to triple its base dividend per share..
Cyanconnode is expanding into South Africa with its smart metering solutions. EVP Rahul Das says the company’s platform is ready for deployment as utilities seek more connected, data-driven infrastructure...
CEO Tony Brewer reveals how the company defied a shrinking market to deliver growth, backed by strategic acquisitions, logistics firepower, and a sales-driven culture...
Hardman & Co’s Mark Thomas explains why NB Private Equity Partners’ 2024 dip is masking a much stronger long-term growth story—one backed by impressive realisation multiples, stable EBITDA growth, and expanding investment opportunities...
EDX Medical Group Plc has joined forces with leading NHS and government health bodies to deliver a rapid hospital-acquired pneumonia test. Sir Chris Evans explains why this partnership could change patient outcomes, cut costs, and accelerate the UK’s precision medicine agenda...
EDX Medical will partner with the Intensive Care Unit at Cambridge University Hospitals NHS Foundation Trust to support the further advancement of a highly precise test that identifies the DNA or RNA of the microbes that cause lung infection in critically ill patients...
CEO Andrew Hume walks us through a significant new agreement with Metals One, a deal that brings in capital and specialist partners while allowing Thor to retain upside exposure..
Stephane Foucaud of Auctus Advisors reveals how robust execution and a cash-rich balance sheet are fuelling both growth and shareholder value. Investors should keep Valeura firmly on their radar...
The trust delivered an exceptional share price performance of +9.9%. This significantly outperformed both the NAV growth (+3.8%) and the FTSE All-World Index (+4.8%)...
New Frontier Minerals has released an expanded suite of preliminary metallurgical results at its Big One Deposit, validating its fast-track production strategy..
Hercules Plc CEO Brusk Korkmaz and CFO Paul Wheatcroft break down their acquisition of Advantage NRG Ltd., explaining why this move anchors the company firmly in the UK’s infrastructure surge..
Leveraging the Prime Oil & Gas amalgamation, the company has doubled its reserves and production base, enabling it to triple its base dividend per share..
Cyanconnode is expanding into South Africa with its smart metering solutions. EVP Rahul Das says the company’s platform is ready for deployment as utilities seek more connected, data-driven infrastructure...
CEO Tony Brewer reveals how the company defied a shrinking market to deliver growth, backed by strategic acquisitions, logistics firepower, and a sales-driven culture...
Hardman & Co’s Mark Thomas explains why NB Private Equity Partners’ 2024 dip is masking a much stronger long-term growth story—one backed by impressive realisation multiples, stable EBITDA growth, and expanding investment opportunities...
